PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) Stock Price, Quote, News & History

Key Statistics

Open

$0.04

Volume / Avg.

9.30K / 53.30K

Day Range

$0.04 - $0.04

52 Wk Range

0.00 - 0.12

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.68

Recent Pharmacielo Ltd News

PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025

Cannabis products company PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) announced on Monday financial and operational results for the three and nine months ended Sept. 30, 2024. The Toronto-based company said revenue for the third quarter totaled CA$1.3 million ($927,772), up from CA$352,000 in the prior year's period. For the nine months, total revenues reached CA$2.4 million, compared to CA$1.3 million in 2023. "PharmaCielo achieved substantial revenue growth, successfully expanded into new international markets, and continued its focus on reducing costs to improve its operational efficiency," Marc Lustig, chairman and CEO of PharmaCielo, said. "Our strategic position in multiple regions, coupled with an expanding product portfolio beyond CBD isolate, has enhanced our ability to serve diverse international markets and generate increased revenue."

Jelena Martinovic

Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify

Colombia's cannabis decree allows dry flower sales, but ex-official claims it won't just protect small producers—most companies may qualify.

Javier Hasse

This European Country Could Lose $242M A Year If It Doesn't Regulate Its Marijuana Market, Study Finds

The Czech Republic could be missing out on hundreds of millions of euros annually as the governing coalition remains persistent in avoiding establishing a regulated marijuana market. That's according to the findings of a comprehensive study examining the possible costs and benefits of various cannabis reform models being proposed nationwide.

Jelena Martinovic

PharmaCielo Cannabis Co. Sees 390% YoY Revenue Jump As Losses Narrow In Q2 2024

PharmaCielo Q2 2024 financial results: 390% revenue boost, improved net loss and strategic share issuance highlight growth and cost cuts.

Patricio Liddle

Cannabis Legalization In Venezuela: Can Maduro Follow Colombia's Lead Amid Political Upheaval And Election Fraud Allegations?

Cannabis In Venezuela: Exploring policy amid political turmoil, potential benefits of reform and lessons from Colombia's legalization.

Patricio Liddle

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.96M

Investing Cash Flow (TTM)

10.05M

Financing Cash Flow (TTM)

-3.04M

Free Cash Flow (TTM)

-6.96M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

54.61K

Valuation Metrics

Enterprise Value

$22.68M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.94

PB Ratio (TTM)

Earnings Yield % (TTM)

-34.88%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.04

Company Debt

Total Debt

$18.21M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$77.50K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$3.57M

Key Statistics

Open

$0.04

Volume / Avg.

9.30K / 53.30K

Day Range

$0.04 - $0.04

52 Wk Range

0.00 - 0.12

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.68

About

Sector

Health Care

Industry

Pharmaceuticals

PharmaCielo Ltd is engaged in the growth, cultivation and development of medicinal cannabis with operations in Colombia. The company operates in one segment.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

PCLOF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

PCLOF

FAQ

How do I buy PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) stock?

You can purchase shares of PHARMACIELO LTD by PHARMACIELO LTD. (OTCPK:PCLOF) through any online brokerage.

View our list of the best stock brokerages

Who are PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) competitors?

There are no as such competitors for PHARMACIELO LTD by PHARMACIELO LTD..

What is the forecast, or price target, for PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) stock?

There is no analysis for PHARMACIELO LTD by PHARMACIELO LTD. to provide a consensus price target.

What is the current price for PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF)?

The stock price for PHARMACIELO LTD by PHARMACIELO LTD. (OTCPK: PCLOF) is $0.0431 last updated September 4, 2026 at 2:50 PM EDT.

Does PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) pay a dividend?

There are no upcoming dividends for PHARMACIELO LTD by PHARMACIELO LTD..

When is PHARMACIELO LTD by PHARMACIELO LTD. (OTCPK:PCLOF) reporting earnings?

PHARMACIELO LTD by PHARMACIELO LTD. does not have any upcoming earnings scheduled.

Is PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) going to split?

There is no upcoming split for PHARMACIELO LTD by PHARMACIELO LTD..

What sector and industry does PHARMACIELO LTD by PHARMACIELO LTD. (PCLOF) operate in?

PHARMACIELO LTD by PHARMACIELO LTD. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.